Latest Expert Opinions

Signal
Opinion
Expert
SELL
SELL
February 8, 2019
He would take profit here and look to re-enter back around $49. He sees 20% possible downside from here based on his model valuation.
BCE Inc.(BCE-T)
February 8, 2019
He would take profit here and look to re-enter back around $49. He sees 20% possible downside from here based on his model valuation.
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$57.370
Owned
Unknown
TOP PICK
TOP PICK
February 8, 2019
He loves the value it provides. He would wait for a return to the December lows to enter -- around $66. Yield 4.47% (Analysts’ price target is $83.10)
Exxon Mobil(XOM-N)
February 8, 2019
He loves the value it provides. He would wait for a return to the December lows to enter -- around $66. Yield 4.47% (Analysts’ price target is $83.10)
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$73.720
Owned
Unknown
TOP PICK
TOP PICK
February 8, 2019
He sees about 18% upside and likes the healthcare sector. Yield 3.43% (Analysts’ price target is $45.85)
Pfizer Inc(PFE-N)
February 8, 2019
He sees about 18% upside and likes the healthcare sector. Yield 3.43% (Analysts’ price target is $45.85)
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$42.095
Owned
Yes
TOP PICK
TOP PICK
February 8, 2019
An old-tech play that still has 71% upside. A new CEO can hopefully shake things up. A good place to hide in the semi-conductor space. You can't even see a measurable pullback in its December trading -- really stands out. Yield 2.6% (Analysts’ price target is $53.00)
Intel(INTC-Q)
February 8, 2019
An old-tech play that still has 71% upside. A new CEO can hopefully shake things up. A good place to hide in the semi-conductor space. You can't even see a measurable pullback in its December trading -- really stands out. Yield 2.6% (Analysts’ price target is $53.00)
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$48.840
Owned
Yes
DON'T BUY
DON'T BUY
February 8, 2019
It pays an 8% yield but has fallen more than that the past year. The trend says lower lows and lower highs. Not attractive. It's approaching and reacting to its 200-day moving average.
It pays an 8% yield but has fallen more than that the past year. The trend says lower lows and lower highs. Not attractive. It's approaching and reacting to its 200-day moving average.
Jon Vialoux
Research Analyst, CastleMoore Inc.
Price
$17.020
Owned
Unknown
DON'T BUY
DON'T BUY
February 8, 2019
Spring is seasonal strength for oil strikes before driving season. Jan.12-April 24 oil gains 10% above the benchmark, positive 12 of 15 years. He's starting to be enticed by the oil stocks. True, CPG suffers lower lows and lower highs, even today. All its moving averages are still down, but this is oversold and due for a bounce. On CPG's side is that oil is in higher demand. But for now, stay away from this.
Spring is seasonal strength for oil strikes before driving season. Jan.12-April 24 oil gains 10% above the benchmark, positive 12 of 15 years. He's starting to be enticed by the oil stocks. True, CPG suffers lower lows and lower highs, even today. All its moving averages are still down, but this is oversold and due for a bounce. On CPG's side is that oil is in higher demand. But for now, stay away from this.
Jon Vialoux
Research Analyst, CastleMoore Inc.
Price
$3.420
Owned
Unknown
BUY
BUY
February 8, 2019
Coincided with the upstick at year's end. October to May sees an uptick in cyclicals like this. It has enjoyed lower lows and lower highs, but has risen above its 200-day moving average which is good--it has gapped higher. We're outside seasonal strength but it's starting to look encouraging.
Chorus Aviation Inc(CHR-T)
February 8, 2019
Coincided with the upstick at year's end. October to May sees an uptick in cyclicals like this. It has enjoyed lower lows and lower highs, but has risen above its 200-day moving average which is good--it has gapped higher. We're outside seasonal strength but it's starting to look encouraging.
Jon Vialoux
Research Analyst, CastleMoore Inc.
Price
$7.080
Owned
Unknown